Rival sues Monsanto, Bayer over GM plant tech

Firms accused of using GM tech for herbicide-resistant plants | Plaintiff says its patented tech helps farmers to innovate | US District Court for the District of Delaware.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Plant Varieties

Plant variety rights: UK holders must act

27 April 2023 An important post-Brexit deadline for UK holders of Retained EU Plant Variety Rights is approaching, explain Alice Smart and Simon Bradbury of Appleyard Lees.

Big Pharma

English High Court finds Bayer patent obvious in win for Teva

11 October 2021 The English High Court has found that a challenged claim of Bayer's targeted cancer drug sorafenib is invalid due to obviousness, in a win for Israeli pharmaceutical company Teva Pharmaceuticals.

Big Pharma

Bayer begins $240m AI drug discovery project with Exscientia

10 January 2020 Germany-based Bayer is collaborating with Exscientia, an artificial intelligence (AI)-driven drug discovery company, to accelerate the discovery of small molecule drugs focused on cardiovascular disease and oncology.

More on this story

Plant Varieties

Plant variety rights: UK holders must act

27 April 2023 An important post-Brexit deadline for UK holders of Retained EU Plant Variety Rights is approaching, explain Alice Smart and Simon Bradbury of Appleyard Lees.

Big Pharma

English High Court finds Bayer patent obvious in win for Teva

Big Pharma

Bayer begins $240m AI drug discovery project with Exscientia

More on this story

Plant Varieties

Plant variety rights: UK holders must act

27 April 2023 An important post-Brexit deadline for UK holders of Retained EU Plant Variety Rights is approaching, explain Alice Smart and Simon Bradbury of Appleyard Lees.

Big Pharma

English High Court finds Bayer patent obvious in win for Teva

Big Pharma

Bayer begins $240m AI drug discovery project with Exscientia